2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Mini-Oral Session

[MO44] Mini-Oral Session 44 Lung Cancer / Thoracic Cancer 7(ICI)
【E】

Sat. Feb 19, 2022 9:55 AM - 10:45 AM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair:Kyoichi Kaira(Department of Respiratory Medicine, Saitama Medical University),Shunichi Sugawara(Department of Pulmonary Medicine, Sendai Kousei Hospital)

[MO44-4] Phase II study of Nivolumab rechallenge in advanced NSCLC pts who responded to prior anti-PD-1/L1 inhibitors; WJOG 9616L

Satoru Miura1, Hiroaki Akamatsu2, Shunsuke Teraoka2, Shinkichi Takamori3, Hidetoshi Hayashi4, Akito Hata5, Yukihiro Toi6, Yoshimasa Shiraishi7, Nobuaki Mamesaya8, Yuki Sato9, Naoki Furuya10, Yasuhiro Koh2, Toshihiro Misumi11, Nobuyuki Yamamoto2, Kazuhiko Nakagawa4 (1.Department of Internal Medicine, Niigata Cancer Center Hospital, 2.Internal Medicine III, Wakayama Medical University, 3.Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, 4.Department of Medical Oncology, Kindai University Faculty of Medicine, 5.Division of Thoracic Oncology, Kobe Minimally Invasive Cancer Center, 6.Department of Pulmonary Medicine, Sendai Kousei Hospital, 7.Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 8.Department of Thoracic Oncology, Shizuoka Cancer Center, 9.Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 10.Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, 11.Department of Biostatistics, Yokohama City University Graduate School of Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password